Trial Profile
Study of Eculizumab for Prevention and Treatment Reperfusion Injury in Kidney Transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2018
Price :
$35
*
At a glance
- Drugs Eculizumab (Primary)
- Indications Reperfusion injury
- Focus Therapeutic Use
- 28 Aug 2018 Status changed from recruiting to completed.
- 07 Dec 2015 New trial record